Trial
NCT01215942
An Open Label Study for Participants With Rheumatoid Arthritis
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Rheumatoid Arthritis
Intervention
LY2127399
Why stopped
Insufficient efficacy observed in study BCDM (NCT01198002) and BCDV (NCT01202773).
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-06-11